NPPA has Served Notice to 22 Pharma Companies

The list of companies that introduced drugs without the approval of National Pharmaceutical Pricing Authority includes big names as Biocon, Dr. Reddy,s Laboratories, lupin, Cipla, Eris Life Sciences and Wockhardt
NPPA has Served Notice to 22 Pharma Companies

New Delhi: National Pharmaceutical Pricing Authority (NPPA) has issued notices to as many as 12 pharma companies notices for introducing drugs without the prior notice to the authorities in the recent past, a press release issued by PIB said. There are as many as 22 drugs that have been introduced by these 12 companies in the Indian market without prior approval of the authority. Most importantly, there are some big pharma names that are expected to be fair and responsible in business.

The NPPA regularly takes action against such companies as per provisions of the Drugs (Prices Control) Order, 2013 (DPCO) which has been issued under the Essential Commodities Act, 1955. The NPPA has so far issued demand notices for an amount of Rs. 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation.

Cases of new drugs are identified from the market-based data being referred to by the NPPA. In addition, new drug cases are also identified through complaint or information received from other sources.

Since the inception of the NPPA in August 1997 till June 2019, 2038 demand notices have been issued to pharmaceutical companies for overcharging patients on the sale of formulations at prices above the ceiling prices notified by the NPPA. Demand notices have been issued for a total amount of Rs. 6370.20 crore, out of which Rs. 893.34 crores have so far been recovered from the pharmaceutical companies. An amount of Rs. 4032.55 crore is under litigation.

Here goes the list of the companies and the drugs:

S. No.Name of the CompanyName of the Drug
1Alembic Pharmaceuticals LtdResync 75/50 mg
2Alembic Pharmaceuticals LtdTrivogo  tablet
3Biocon limitedBlisto Trio 0.2/500/2 mg
4Biocon limitedBlisto Trio 0.2/500/1 mg
5BoehringerIngelheim India Pvt. Ltd and Kemwell Biopharma Pvt. LtdBuscogast plus Tablets
6Cipla LimitedHepcvel Tablets
7Dr. Reddy's Laboratories LtdResof total 400/100 mg
8Eris Life Sciences Pvt LtdCyblex MV 80.3
9Eris Life Sciences Pvt LtdCyblex M 30
10Eris Life Sciences Pvt LtdCyblex M 60
11Eris Life Sciences Pvt LtdCyblex MV 80.2
12Eris Life Sciences Pvt LtdCyblex M 80
13Eris Life Sciences Pvt LtdCyblex M 40
14Hetero Healthcare LimitedVelasof Tablets
15Hetero Healthcare Limited / Cadila Healthcare LimitedSovip V Tablets
16Ipca Laboratories LimitedPacimol Active
17lupin limitedGluconorm VG pluse-1
18lupin limitedGluconorm VG pluse-2
19Sanofi India LimitedAmaryl MV 0.2 mg /500/1 mg
20Sanofi India LimitedAmaryl MV 0.2 mg /500/1 mg pack of 15 tabs
21Unichem Laboratories pvt.ltdTritelsar-80+5 similer formulation
22Wockhardt Liited and  Medibios Laboratories LimitedAlphadopa 500mg  tab

This information was given in a written reply by the Union Minister for the Chemicals & Fertilizers, D .V. Sadananda Gowda in the Lok  Sabha on Monday.

logo
PSU Watch
psuwatch.com